[Skip to Content]
[Skip to Content Landing]
Article
September 1961

Serum Cholesterol Level in Cerebral Infarction

Author Affiliations

DURHAM, N.C.; WASHINGTON, D.C.; DURHAM, N.C.
From the Department of Medicine, (Neurology and Cardiology Divisions), Veterans Administration Hospital, and Duke University Medical Center, and from the National Academy of Sciences, National Research Council, Division of Medical Research.

Arch Neurol. 1961;5(3):264-268. doi:10.1001/archneur.1961.00450150030003
Abstract

For many years hypercholesterolemia has been associated with the development of atherosclerosis in experimental animals and with an increased incidence of coronary thrombosis in man. The correlation between elevated serum cholesterol and atherosclerotic heart disease has led to the therapeutic use of cholesterol-reducing diets and medications in patients with this disorder. On the other hand, the correlation between cerebral thrombosis and hypercholesterolemia has been less well studied, and efforts to reduce serum cholesterol in this form of atherosclerosis have not been widely recommended. Patients with cerebral atherosclerosis might be expected to have an elevation of serum cholesterol comparable to that found in coronary vascular disease; however, differences in age, sex, and racial incidence of the 2 diseases could possibly produce differences in the level of this serum lipid. Coronary thrombosis, for example, occurs much more frequently in males,1 appears in lower age groups,2 and has a lower incidence

First Page Preview View Large
First page PDF preview
First page PDF preview
×